{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T09:10:29Z","timestamp":1773047429152,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Radiotherapy (RT) is effective for cervical cancer but causes late side effects (SE) to nearby organs. These late SE occur more than 3 months after RT and are rated by clinical findings to determine their severity. While imaging studies describe late gastrointestinal (GI) SE, none demonstrate the correlation between the findings and the toxicity grading. In this study, we demonstrated the late GI toxicity prevalence, CT findings, and their correlation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We retrospectively studied uterine cervical cancer patients treated with RT between 2015 and 2018. Patient characteristics and treatment(s) were obtained from the hospital\u2019s databases. Late RTOG\/EORTC GI SE and CT images were obtained during the follow-up. Post-RT GI changes were reviewed from CT images using pre-defined criteria. Risk ratios (RR) were calculated for CT findings, and multivariable log binomial regression determined adjusted RRs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>This study included 153 patients, with a median age of 57 years (IQR 49\u201365). The prevalence of \u2265\u2009grade 2 RTOG\/EORTC late GI SE was 33 (27.5%). CT findings showed 91 patients (59.48%) with enhanced bowel wall (BW) thickening, 3 (1.96%) with bowel obstruction, 7 (4.58%) with bowel perforation, 6 (3.92%) with fistula, 0 (0%) with bowel ischemia, and 0 (0%) with GI bleeding. Adjusted RRs showed that enhanced BW thickening (RR 9.77, 95% CI 2.64\u201336.07, <jats:italic>p<\/jats:italic>\u2009=\u20090.001), bowel obstruction (RR 5.05, 95% CI 2.30\u201311.09, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), and bowel perforation (RR 3.82, 95% CI 1.96\u20137.44, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) associated with higher late GI toxicity grades.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our study shows CT findings correlate with grade 2\u20134 late GI toxicity. Future research should validate and refine these findings with different imaging and toxicity grading systems to assess their potential predictive value.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12880-024-01420-3","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T12:02:29Z","timestamp":1725883349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Utilizing CT imaging for evaluating late gastrointestinal tract side effects of radiotherapy in uterine cervical cancer: a risk regression analysis"],"prefix":"10.1186","volume":"24","author":[{"given":"Pooriwat","family":"Muangwong","sequence":"first","affiliation":[]},{"given":"Nutthita","family":"Prukvaraporn","sequence":"additional","affiliation":[]},{"given":"Kittikun","family":"Kittidachanan","sequence":"additional","affiliation":[]},{"given":"Nattharika","family":"Watthanayuenyong","sequence":"additional","affiliation":[]},{"given":"Imjai","family":"Chitapanarux","sequence":"additional","affiliation":[]},{"given":"Wittanee","family":"Na Chiangmai","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,9,9]]},"reference":[{"key":"1420_CR1","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1136\/ijgc-2023-004429","volume":"33","author":"D Cibula","year":"2023","unstructured":"Cibula D, Raspollini MR, Planchamp F, Centeno C, Chargari C, Felix A, et al. ESGO\/ESTRO\/ESP guidelines for the management of patients with cervical cancer - update 2023. Int J Gynecol Cancer. 2023;33:649\u201366.","journal-title":"Int J Gynecol Cancer"},{"key":"1420_CR2","unstructured":"National Comprehensive Cancer Network. Cervical Cancer. (Version 1.2023). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cervical.pdf. Accessed 24 Aug 2023."},{"key":"1420_CR3","doi-asserted-by":"publisher","first-page":"iv72","DOI":"10.1093\/annonc\/mdx220","volume":"28","author":"C Marth","year":"2017","unstructured":"Marth C, Landoni F, Mahner S, McCormack M, Gonzalez-Martin A, Colombo N. Cervical cancer: ESMO Clinical Practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28:iv72\u201383.","journal-title":"Ann Oncol"},{"key":"1420_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/codi.12812","volume":"17","author":"HJN Andreyev","year":"2015","unstructured":"Andreyev HJN. Pelvic radiation disease. Color Dis. 2015;17:2\u20136.","journal-title":"Color Dis"},{"key":"1420_CR5","doi-asserted-by":"publisher","first-page":"400","DOI":"10.4251\/wjgo.v13.i5.400","volume":"13","author":"H McCaughan","year":"2021","unstructured":"McCaughan H, Boyle S, McGoran JJ. Update on the management of the gastrointestinal effects of radiation. World J Gastrointest Oncol. 2021;13:400\u20138.","journal-title":"World J Gastrointest Oncol"},{"key":"1420_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.clon.2009.10.003","volume":"22","author":"VS Theis","year":"2010","unstructured":"Theis VS, Sripadam R, Ramani V, Lal S. Chronic Radiation Enteritis. Clin Oncol. 2010;22:70\u201383.","journal-title":"Clin Oncol"},{"key":"1420_CR7","doi-asserted-by":"publisher","first-page":"272","DOI":"10.5306\/wjco.v6.i6.272","volume":"6","author":"L Frazzoni","year":"2015","unstructured":"Frazzoni L, Marca M, La, Guido A, Morganti AG, Bazzoli F, Fuccio L. Pelvic radiation disease: updates on treatment options. World J Clin Oncol. 2015;6:272\u201380.","journal-title":"World J Clin Oncol"},{"key":"1420_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.icrp.2012.02.001","volume":"41","author":"FA Stewart","year":"2012","unstructured":"Stewart FA, Akleyev AV, Hauer-Jensen M, Hendry JH, Kleiman NJ, MacVittie TJ, et al. ICRP PUBLICATION 118: ICRP Statement on tissue reactions and early and late effects of Radiation in Normal tissues and organs \u2014 threshold doses for tissue reactions in a Radiation Protection Context. Ann ICRP. 2012;41:1\u2013322.","journal-title":"Ann ICRP"},{"key":"1420_CR9","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/j.1365-2559.1985.tb02833.x","volume":"9","author":"PS Hasleton","year":"1985","unstructured":"Hasleton PS, Carr N, Schofield PF. Vascular changes in radiation bowel disease. Histopathology. 1985;9:517\u201334.","journal-title":"Histopathology"},{"key":"1420_CR10","doi-asserted-by":"publisher","first-page":"7289","DOI":"10.3748\/wjg.14.7289","volume":"14","author":"J Kountouras","year":"2008","unstructured":"Kountouras J, Zavos C. Recent advances in the management of radiation colitis. World J Gastroenterol. 2008;14:7289.","journal-title":"World J Gastroenterol"},{"key":"1420_CR11","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.clon.2007.08.011","volume":"19","author":"HJN Andreyev","year":"2007","unstructured":"Andreyev HJN. Gastrointestinal problems after pelvic radiotherapy: the past, the Present and the future. Clin Oncol. 2007;19:790\u20139.","journal-title":"Clin Oncol"},{"key":"1420_CR12","unstructured":"U.S. Department of Health and Human Service. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. 2017. https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_8.5x11.pdf. Accessed 16 Jun 2019."},{"key":"1420_CR13","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","volume":"31","author":"JD Cox","year":"1995","unstructured":"Cox JD, Stetz JA, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1420_CR14","doi-asserted-by":"crossref","unstructured":"Lent soma scales for all anatomic sites. Int J Radiat Oncol. 1995;31:1049\u201391.","DOI":"10.1016\/0360-3016(95)90159-0"},{"key":"1420_CR15","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1007\/s00520-013-1782-y","volume":"21","author":"CC Henson","year":"2013","unstructured":"Henson CC, Davidson SE, Ang Y, Babbs C, Crampton J, Kelly M, et al. Structured gastroenterological intervention and improved outcome for patients with chronic gastrointestinal symptoms following pelvic radiotherapy. Support Care Cancer. 2013;21:2255\u201365.","journal-title":"Support Care Cancer"},{"key":"1420_CR16","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1148\/rg.307105063","volume":"30","author":"HC Addley","year":"2010","unstructured":"Addley HC, Vargas HA, Moyle PL, Crawford R, Sala E. Pelvic imaging following chemotherapy and radiation therapy for gynecologic malignancies. Radiographics. 2010;30:1843\u201356.","journal-title":"Radiographics"},{"key":"1420_CR17","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1148\/rg.332125119","volume":"33","author":"KE Maturen","year":"2013","unstructured":"Maturen KE, Feng MU, Wasnik AP, Azar SF, Appelman HD, Francis IR, et al. Imaging effects of radiation therapy in the abdomen and pelvis: evaluating innocent bystander tissues. Radiographics. 2013;33:599\u2013619.","journal-title":"Radiographics"},{"key":"1420_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3348\/kjr.2009.10.1.63","volume":"10","author":"HK Sung","year":"2009","unstructured":"Sung HK, Sang SS, Yong YJ, Suk HH, Jin WK, Heoung KK. Gastrointestinal tract perforation: MDCT findings according to the perforation sites. Korean J Radiol. 2009;10:63\u201370.","journal-title":"Korean J Radiol"},{"key":"1420_CR19","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1148\/radiographics.22.5.g02se201093","volume":"22","author":"J Wittenberg","year":"2002","unstructured":"Wittenberg J, Harisinghani MG, Jhaveri K, Varghese J, Mueller PR. Algorithmic approach to CT diagnosis of the abnormal bowel wall. Radiographics. 2002;22:1093\u2013107.","journal-title":"Radiographics"},{"key":"1420_CR20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1102\/1470-7330.2012.0014","volume":"12","author":"C Viswanathan","year":"2012","unstructured":"Viswanathan C, Bhosale P, Ganeshan DM, Truong MT, Silverman P, Balachandran A. Imaging of complications of oncological therapy in the gastrointestinal system. Cancer Imaging. 2012;12:163\u201372.","journal-title":"Cancer Imaging"},{"key":"1420_CR21","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s00066-012-0156-6","volume":"188","author":"K Kirchheiner","year":"2012","unstructured":"Kirchheiner K, Nout R, Lindegaard J, Petri\u010d P, Limbergen EV, J\u00fcrgenliemk-Schulz IM, et al. Do clinicians and patients agree regarding symptoms? A comparison after definitive radiochemotherapy in 223 uterine cervical cancer patients. Strahlentherapie Und Onkol. 2012;188:933\u20139.","journal-title":"Strahlentherapie Und Onkol"},{"key":"1420_CR22","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.ijrobp.2007.12.030","volume":"71","author":"I Vistad","year":"2008","unstructured":"Vistad I, Cvancarova M, Foss\u00e5 SD, Kristensen GB. Postradiotherapy Morbidity in Long-Term survivors after locally Advanced Cervical Cancer: how well do Physicians\u2019 assessments agree with those of their patients? Int J Radiat Oncol. 2008;71:1335\u201342.","journal-title":"Int J Radiat Oncol"},{"key":"1420_CR23","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1200\/JCO.2014.57.9334","volume":"33","author":"M Di Maio","year":"2015","unstructured":"Di Maio M, Gallo C, Leighl NB, Piccirillo MC, Daniele G, Nuzzo F, et al. Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials. J Clin Oncol. 2015;33:910\u20135.","journal-title":"J Clin Oncol"},{"key":"1420_CR24","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.radonc.2018.05.016","volume":"127","author":"NBK Jensen","year":"2018","unstructured":"Jensen NBK, P\u00f6tter R, Kirchheiner K, Fokdal L, Lindegaard JC, Kirisits C, et al. Bowel morbidity following radiochemotherapy and image-guided adaptive brachytherapy for cervical cancer: physician- and patient reported outcome from the EMBRACE study. Radiother Oncol. 2018;127:431\u20139.","journal-title":"Radiother Oncol"},{"key":"1420_CR25","doi-asserted-by":"publisher","first-page":"229","DOI":"10.31083\/j.ceog5011229","volume":"50","author":"AR Besharat","year":"2023","unstructured":"Besharat AR, Giannini A, Caserta D. Pathogenesis and treatments of endometrial carcinoma. Clin Exp Obstet Gynecol. 2023;50:229.","journal-title":"Clin Exp Obstet Gynecol"},{"key":"1420_CR26","doi-asserted-by":"publisher","first-page":"210","DOI":"10.31083\/j.ceog5010210","volume":"50","author":"O D\u2019Oria","year":"2023","unstructured":"D\u2019Oria O, Giannini A, Besharat AR, Caserta D. Management of Endometrial Cancer: Molecular Identikit and tailored therapeutic Approach. Clin Exp Obstet Gynecol. 2023;50:210.","journal-title":"Clin Exp Obstet Gynecol"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-024-01420-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-024-01420-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-024-01420-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T12:04:48Z","timestamp":1725883488000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-024-01420-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,9]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1420"],"URL":"https:\/\/doi.org\/10.1186\/s12880-024-01420-3","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,9]]},"assertion":[{"value":"19 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by Research Ethic Committee No. 4, Faculty of Medicine, Chiang Mai University (Approval No. 499\/2021). The data collection was authorized by the faculty. Informed consent was not required by the faculty and Research Ethic Committee due to retrospective study with anonymized patient identification. This study was carried out in accordance with the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"Not Applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"235"}}